AbbVie Inc (ABBV)
171.70
+3.94
(+2.35%)
USD |
NYSE |
Nov 21, 16:00
172.28
+0.58
(+0.34%)
After-Hours: 18:55
AbbVie Price to Book Value: 50.30 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 49.15 |
| November 19, 2024 | 48.80 |
| November 18, 2024 | 48.71 |
| November 15, 2024 | 48.34 |
| November 14, 2024 | 49.70 |
| November 13, 2024 | 49.91 |
| November 12, 2024 | 50.12 |
| November 11, 2024 | 51.10 |
| November 08, 2024 | 58.45 |
| November 07, 2024 | 58.74 |
| November 06, 2024 | 58.94 |
| November 05, 2024 | 59.08 |
| November 04, 2024 | 58.73 |
| November 01, 2024 | 59.63 |
| October 31, 2024 | 59.73 |
| October 30, 2024 | 59.03 |
| October 29, 2024 | 55.50 |
| October 28, 2024 | 55.57 |
| October 25, 2024 | 55.03 |
| October 24, 2024 | 55.56 |
| October 23, 2024 | 55.04 |
| October 22, 2024 | 55.30 |
| October 21, 2024 | 54.65 |
| October 18, 2024 | 55.33 |
| October 17, 2024 | 55.24 |
| Date | Value |
|---|---|
| October 16, 2024 | 55.80 |
| October 15, 2024 | 56.21 |
| October 14, 2024 | 57.32 |
| October 11, 2024 | 56.89 |
| October 10, 2024 | 56.94 |
| October 09, 2024 | 57.05 |
| October 08, 2024 | 56.54 |
| October 07, 2024 | 56.72 |
| October 04, 2024 | 56.92 |
| October 03, 2024 | 57.26 |
| October 02, 2024 | 57.66 |
| October 01, 2024 | 57.70 |
| September 30, 2024 | 57.85 |
| September 27, 2024 | 50.76 |
| September 26, 2024 | 50.01 |
| September 25, 2024 | 49.84 |
| September 24, 2024 | 50.43 |
| September 23, 2024 | 50.51 |
| September 20, 2024 | 50.42 |
| September 19, 2024 | 50.46 |
| September 18, 2024 | 50.28 |
| September 17, 2024 | 50.41 |
| September 16, 2024 | 51.01 |
| September 13, 2024 | 50.61 |
| September 12, 2024 | 50.56 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
9.306
Minimum
Oct 28 2020
59.73
Maximum
Oct 31 2024
21.30
Average
16.87
Median
Price to Book Value Benchmarks
| Amgen Inc | 20.70 |
| Johnson & Johnson | 5.336 |
| Eli Lilly and Co | 49.99 |
| Merck & Co Inc | 5.676 |
| Pfizer Inc | 1.543 |
Price to Book Value Related Metrics
| PE Ratio | 59.62 |
| PS Ratio | 5.482 |
| Price to Free Cash Flow | 19.49 |
| Price | 171.70 |
| Earnings Yield | 1.68% |
| Market Cap | 303.42B |
| Operating PE Ratio | 20.98 |
| Normalized PE Ratio | 54.42 |